VIB Vermögen AG
- WKN: A2YPDD
- ISIN: DE000A2YPDD0
- Land: Deutschland
Nachricht vom 01.10.2021 | 07:30
VIB Vermögen AG optimizes portfolio by selling the 'Kinopark' cinema/retail park in Aalen
DGAP-News: VIB Vermögen AG
/ Key word(s): Disposal/Real Estate
Neuburg/Danube, October 1, 2021 - VIB Vermögen AG, a company specializing in the development, acquisition and portfolio management of commercial properties, continues to persue its strategy of selective portfolio optimization in the retail segment with the sale of the "Kinopark" cinema/retail park in Aalen.
The property is a 10,200 square metres retail park with the Aalen cinema and Norma as anchor tenants. The purchaser is SWT Immobilien Verwaltungs GmbH from Rain/Lech. The parties have agreed not to disclose the purchase price.
VIB Vermögen AG
VIB Vermögen AG is a medium-sized company specialising in commercial real estate management that has been operating successfully for more than 25 years. It focuses on properties from the logistics/light industry and retail sectors in the economically strong southern German region. VIB's shares have been listed on the Munich (m:access) and Frankfurt (Open Market) stock exchanges since 2005.
VIB's business model is based on a "develop-or-buy-and-hold" strategy. Firstly, VIB acquires properties that are already rented. Secondly, it completely develops new properties in order to transfer them to its own portfolio on a long-term basis and generate rental income from them. VIB also holds investments in companies with real estate assets.
|Company:||VIB Vermögen AG|
|Phone:||+49 (0)8431 / 9077 952|
|Fax:||+49 (0)8431 / 9077 973|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Hamburg, Munich (m:access), Stuttgart, Tradegate Exchange|
|EQS News ID:||1237351|
|End of News||DGAP News Service|
VIB Vermögen AG: VIB with successful follow-up ...
VIB Vermögen AG: VIB Vermögen significantly in ...
VIB Vermögen AG optimizes portfolio by selling ...
VIB Vermögen AG again wins EPRA Gold Awards in ...
VIB Vermögen AG with significant growth in rev ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
02. Dezember 08:12 Infineon-Aktie: Apple, Omikron und Co belasten - das ist zu tun!
02. Dezember 08:24 Heidelberger Druck: Das ist der wichtigste Kurstreiber
02. Dezember 08:25 Salesforce: Der Zahlen-Schock sitzt tief
02. Dezember 08:28 Volkswagen: Neuer Kurstreiber für die Aktie?!
02. Dezember 08:30 Zalando: Das macht jetzt Hoffnung
News im Fokus
Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025
01. Dezember 2021, 15:38
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: Bio-Gate AG (von GBC AG): Kaufen
02. Dezember 2021